Skip to contentM
Myriad Genetics Inc
M
MYGNMyriad Genetics Inc Source filing unavailable
Q4 2013 · —
derived · Computed from the longer spans the company filed.
Revenue$174.15M$174.15Mderived+31.0% vs Q4 2012 Net Income$44.14M$44.14Mderived+51.5% vs Q4 2012 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$65,914,000+39.4% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
Operating Cash Flowderived$63,000,000+51.1% Free Cash Flowderived$60,182,000+52.3% Margins · derivedOperating margin37.8%+2.3 pt vs Q4 2012
Net margin25.3%+3.4 pt vs Q4 2012